| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 6.87e-05 | 2 | 166 | 2 | GO:0005093 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.71e-06 | 145 | 166 | 9 | GO:0001578 | |
| GeneOntologyBiologicalProcess | regulation of hippo signaling | 1.47e-05 | 39 | 166 | 5 | GO:0035330 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 CLASP1 NUMA1 TOGARAM1 DNAH7 DICER1 SPICE1 ABRAXAS2 PPP2R1A LLGL2 NAT10 FES TTL NINL CFAP69 ANKFN1 DNAH8 HYDIN | 2.11e-05 | 720 | 166 | 18 | GO:0000226 |
| GeneOntologyCellularComponent | axonemal central pair projection | 6.42e-05 | 2 | 168 | 2 | GO:1990718 | |
| Domain | ARM-type_fold | TNPO1 RALGAPA1 USP34 SMG1 NCAPD3 TRPC4AP RAP1GDS1 CLASP1 TNPO2 VEPH1 TOGARAM1 HUWE1 ARMCX3 PPP2R1A TTI1 UTP20 BRAT1 CFAP69 NIPBL TARBP1 ARMC8 | 3.35e-12 | 339 | 167 | 21 | IPR016024 |
| Domain | HEAT_REPEAT | TNPO1 SMG1 NCAPD3 CLASP1 TNPO2 TOGARAM1 PPP2R1A UTP20 BRAT1 NIPBL ARMC8 | 2.88e-11 | 70 | 167 | 11 | PS50077 |
| Domain | ARM-like | TNPO1 SMG1 NCAPD3 RAP1GDS1 CLASP1 TNPO2 TOGARAM1 HUWE1 ARMCX3 PPP2R1A TTI1 UTP20 BRAT1 CFAP69 NIPBL TARBP1 ARMC8 | 3.39e-10 | 270 | 167 | 17 | IPR011989 |
| Domain | HEAT | TNPO1 NCAPD3 CLASP1 TNPO2 TOGARAM1 PPP2R1A UTP20 BRAT1 NIPBL | 2.15e-09 | 58 | 167 | 9 | IPR000357 |
| Domain | - | TNPO1 NCAPD3 RAP1GDS1 CLASP1 TNPO2 TOGARAM1 ARMCX3 PPP2R1A TTI1 UTP20 BRAT1 CFAP69 NIPBL ARMC8 | 1.29e-08 | 222 | 167 | 14 | 1.25.10.10 |
| Domain | HEAT | 2.18e-07 | 48 | 167 | 7 | PF02985 | |
| Domain | Vinculin/catenin | 2.39e-05 | 7 | 167 | 3 | IPR006077 | |
| Domain | RabGDI | 7.95e-05 | 2 | 167 | 2 | IPR000806 | |
| Domain | LANC-like | 2.37e-04 | 3 | 167 | 2 | IPR007822 | |
| Domain | LANC_like | 2.37e-04 | 3 | 167 | 2 | SM01260 | |
| Domain | SpoU_MeTrfase | 2.37e-04 | 3 | 167 | 2 | IPR001537 | |
| Domain | LANC_like | 2.37e-04 | 3 | 167 | 2 | PF05147 | |
| Domain | LanC-like_prot_euk | 2.37e-04 | 3 | 167 | 2 | IPR020464 | |
| Domain | SpoU_methylase | 2.37e-04 | 3 | 167 | 2 | PF00588 | |
| Domain | - | 4.71e-04 | 4 | 167 | 2 | 3.40.1280.10 | |
| Domain | Alpha_catenin | 4.71e-04 | 4 | 167 | 2 | IPR001033 | |
| Domain | GDI | 4.71e-04 | 4 | 167 | 2 | PF00996 | |
| Domain | tRNA_m1G_MTases_N | 4.71e-04 | 4 | 167 | 2 | IPR029026 | |
| Domain | GDP_dissociation_inhibitor | 4.71e-04 | 4 | 167 | 2 | IPR018203 | |
| Domain | Vinculin | 7.81e-04 | 5 | 167 | 2 | PF01044 | |
| Domain | Armadillo | 8.15e-04 | 47 | 167 | 4 | IPR000225 | |
| Domain | - | 9.54e-04 | 22 | 167 | 3 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 1.09e-03 | 23 | 167 | 3 | IPR009091 | |
| Domain | RIH_assoc-dom | 1.16e-03 | 6 | 167 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.16e-03 | 6 | 167 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.16e-03 | 6 | 167 | 2 | PF08454 | |
| Domain | RIH_dom | 1.16e-03 | 6 | 167 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.16e-03 | 6 | 167 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.16e-03 | 6 | 167 | 2 | IPR015925 | |
| Domain | Alpha/beta_knot_MTases | 1.16e-03 | 6 | 167 | 2 | IPR029028 | |
| Domain | - | 1.16e-03 | 6 | 167 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.16e-03 | 6 | 167 | 2 | PF01365 | |
| Domain | Kinase-like_dom | SMG1 FLT3 ROR2 MKNK2 CDKL4 SNRK SGK2 NEK8 FES KNDC1 ROS1 PRKD1 MAP4K4 | 1.20e-03 | 542 | 167 | 13 | IPR011009 |
| Domain | ZnF_UBR1 | 1.62e-03 | 7 | 167 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.62e-03 | 7 | 167 | 2 | PS51157 | |
| Domain | zf-UBR | 1.62e-03 | 7 | 167 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.62e-03 | 7 | 167 | 2 | IPR003126 | |
| Domain | VWF_A | 1.96e-03 | 99 | 167 | 5 | IPR002035 | |
| Domain | 6hp_glycosidase | 2.15e-03 | 8 | 167 | 2 | IPR012341 | |
| Domain | - | 2.15e-03 | 8 | 167 | 2 | 1.50.10.10 | |
| Domain | Arm | 2.63e-03 | 31 | 167 | 3 | PF00514 | |
| Domain | - | 2.78e-03 | 391 | 167 | 10 | 2.30.29.30 | |
| Domain | PROTEIN_KINASE_ATP | 2.86e-03 | 459 | 167 | 11 | PS00107 | |
| Domain | MIR | 3.41e-03 | 10 | 167 | 2 | PF02815 | |
| Domain | MIR_motif | 3.41e-03 | 10 | 167 | 2 | IPR016093 | |
| Domain | MIR | 3.41e-03 | 10 | 167 | 2 | PS50919 | |
| Domain | MIR | 3.41e-03 | 10 | 167 | 2 | SM00472 | |
| Domain | PKD_channel | 4.15e-03 | 11 | 167 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 4.15e-03 | 11 | 167 | 2 | IPR013122 | |
| Domain | Prot_kinase_dom | 4.60e-03 | 489 | 167 | 11 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 4.88e-03 | 493 | 167 | 11 | PS50011 | |
| Domain | GrpE_coiled_coil | 4.95e-03 | 12 | 167 | 2 | IPR013805 | |
| Domain | PH_dom-like | 5.08e-03 | 426 | 167 | 10 | IPR011993 | |
| Domain | ARM_REPEAT | 5.44e-03 | 40 | 167 | 3 | PS50176 | |
| Domain | 6-hairpin_glycosidase-like | 5.81e-03 | 13 | 167 | 2 | IPR008928 | |
| Domain | RanBD | 5.81e-03 | 13 | 167 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 5.81e-03 | 13 | 167 | 2 | IPR000156 | |
| Domain | VWFA | 6.28e-03 | 82 | 167 | 4 | PS50234 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.74e-03 | 14 | 167 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.74e-03 | 14 | 167 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.74e-03 | 14 | 167 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.74e-03 | 14 | 167 | 2 | PF08393 | |
| Domain | IMPORTIN_B_NT | 6.74e-03 | 14 | 167 | 2 | PS50166 | |
| Domain | ATPase_dyneun-rel_AAA | 6.74e-03 | 14 | 167 | 2 | IPR011704 | |
| Domain | MT | 6.74e-03 | 14 | 167 | 2 | PF12777 | |
| Domain | AAA_8 | 6.74e-03 | 14 | 167 | 2 | PF12780 | |
| Domain | AAA_5 | 6.74e-03 | 14 | 167 | 2 | PF07728 | |
| Domain | VWA | 6.83e-03 | 84 | 167 | 4 | SM00327 | |
| Domain | Protein_kinase_ATP_BS | 7.18e-03 | 379 | 167 | 9 | IPR017441 | |
| Domain | DHC_fam | 7.73e-03 | 15 | 167 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 7.73e-03 | 15 | 167 | 2 | PF03028 | |
| Domain | LY | 7.73e-03 | 15 | 167 | 2 | SM00135 | |
| Domain | IBN_N | 7.73e-03 | 15 | 167 | 2 | PF03810 | |
| Domain | Dynein_heavy_dom | 7.73e-03 | 15 | 167 | 2 | IPR004273 | |
| Domain | LDLR_classB_rpt | 7.73e-03 | 15 | 167 | 2 | IPR000033 | |
| Domain | Tyr_kinase_cat_dom | 8.03e-03 | 88 | 167 | 4 | IPR020635 | |
| Domain | TyrKc | 8.03e-03 | 88 | 167 | 4 | SM00219 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.04e-03 | 138 | 167 | 5 | IPR001245 | |
| Domain | IBN_N | 8.78e-03 | 16 | 167 | 2 | SM00913 | |
| Pubmed | TNPO1 USP34 NUMA1 URB2 HUWE1 GDI1 GDI2 DICER1 ITPR3 PPP2R1A NOP58 NOP14 MDN1 UBR5 ANAPC1 TLN1 MCM3AP NAT10 MKI67 UTP20 CNOT1 NIPBL | 1.39e-12 | 653 | 170 | 22 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TNPO1 NUP50 NCAPD3 NUMA1 LANCL1 URB2 HUWE1 GDI2 DICER1 NPM3 MRM3 PPP2R1A NOP58 METTL13 MDN1 CLIC1 ANAPC1 EIF2B1 TLN1 NAT10 ENAH ANP32A MKI67 CSTF1 UTP20 PLPBP MAP4K4 CNOT1 NIPBL ARMC8 | 1.41e-11 | 1425 | 170 | 30 | 30948266 |
| Pubmed | TNPO1 PRPSAP1 USP34 SMG1 NCAPD3 TNPO2 NUMA1 CARD10 HUWE1 SKP2 SNX19 DICER1 NPM3 LRCH3 ITPR3 LIFR PPP2R1A NOP58 MDN1 UBR5 CLIC1 EIF2B1 TLN1 NAT10 ANP32A MKI67 TRAPPC10 CNOT1 MX1 ARMC8 | 1.82e-11 | 1440 | 170 | 30 | 30833792 | |
| Pubmed | CLASP1 USP28 NUMA1 DGKZ HUWE1 BCR GDI1 GDI2 ITIH1 STRIP1 SPICE1 PPP2R1A MDN1 UBR5 ANAPC1 NAT10 ENAH PRKD1 MAP4K4 TNS1 CNOT1 NIPBL ARMC8 | 3.97e-10 | 963 | 170 | 23 | 28671696 | |
| Pubmed | TNPO1 USP34 NUP50 NELFCD USP28 NUMA1 CHD1L GDI2 KANSL3 PPP2R1A NOP58 MDN1 UBR5 CLIC1 ANAPC1 EIF2B1 NAT10 ANP32A MKI67 CSTF1 BRAT1 NIPBL CWF19L1 | 1.07e-09 | 1014 | 170 | 23 | 32416067 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 CLASP1 CARD10 CHD1L HUWE1 ORC5 PPP2R1A METTL13 MDN1 ANAPC1 TLN1 NAT10 ENAH COPS6 CNOT1 NIPBL GULP1 | 4.81e-09 | 582 | 170 | 17 | 20467437 |
| Pubmed | RALGAPA1 USP34 SMG1 NEMP1 NCAPD3 SDK2 USP28 SNRK BCR DICER1 KANSL3 NAT10 NINL RAI14 MAP4K4 CNOT1 | 8.57e-09 | 529 | 170 | 16 | 14621295 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 NUMA1 LANCL1 CHD1L URB2 HUWE1 MTHFS MCM10 NPM3 PPP2R1A NOP58 METTL13 ARHGEF40 NOP14 MDN1 UBR5 CLIC1 TLN1 MCM3AP NAT10 MKI67 CSTF1 UTP20 RAI14 NIPBL | 1.17e-08 | 1353 | 170 | 25 | 29467282 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | RALGAPA1 NUP50 RAP1GDS1 USP28 TNPO2 URB2 DICER1 ARMCX3 LRCH3 PPP2R1A MDN1 UBR5 RCBTB1 EIF2B1 NINL TTI1 UTP20 BRAT1 | 3.67e-08 | 754 | 170 | 18 | 33060197 |
| Pubmed | RALGAPA1 CLASP1 SKP2 STRIP1 LRCH3 SPICE1 ABRAXAS2 PPP2R1A UBR5 ANAPC1 NINL TRAPPC10 MAP4K4 CNOT1 | 4.81e-08 | 446 | 170 | 14 | 24255178 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NUP50 TRPC4AP CLASP1 NUMA1 SKP2 GDI2 STRIP1 SPICE1 KANSL3 ORC5 PPP2R1A NOP58 LLGL2 UBR5 ANAPC1 TLN1 MKI67 RAI14 TEN1 COPS6 CNOT1 NIPBL | 5.70e-08 | 1155 | 170 | 22 | 20360068 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TNPO1 USP34 NUP50 NCAPD3 TRPC4AP CTNNAL1 CLASP1 DGKZ HUWE1 BCR MTMR10 DICER1 ARMCX3 ITPR3 ABRAXAS2 PTPDC1 PPP2R1A UBR5 CSTF1 ARMC8 | 7.24e-08 | 974 | 170 | 20 | 28675297 |
| Pubmed | RALGAPA1 NUP50 CTNNAL1 HUWE1 SNX19 MTMR10 MADD SPICE1 ITPR3 ABRAXAS2 PTPDC1 PPP2R1A NOP14 NAT10 ENAH MKI67 TTI1 RAI14 TNS1 CNOT1 | 2.36e-07 | 1049 | 170 | 20 | 27880917 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NEMP1 NCAPD3 NELFCD USP28 CHD1L HUWE1 SKP2 KANSL3 ORC5 METTL13 NOP14 MDN1 UBR5 ANAPC1 RCBTB1 UTP20 ALB ARMC8 | 2.45e-07 | 857 | 170 | 18 | 25609649 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TNPO1 PRPSAP1 CLASP1 TMEM39B CHD1L DICER1 RCBTB1 ENAH PTCD2 TTI1 RAI14 TEN1 MAP4K4 NIPBL | 4.47e-07 | 536 | 170 | 14 | 15840001 |
| Pubmed | TNPO1 PRPSAP1 CLASP1 TMEM39B CHD1L DICER1 RCBTB1 ENAH PTCD2 TTI1 RAI14 TEN1 MAP4K4 NIPBL | 4.68e-07 | 538 | 170 | 14 | 10512203 | |
| Pubmed | TNPO1 UBR1 NUMA1 MCM10 BCR ARMCX3 NOP58 UBR5 ANAPC1 ANP32A TTI1 CNOT1 | 5.57e-07 | 390 | 170 | 12 | 17643375 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TNPO1 NUP50 TRPC4AP CLASP1 NPHP4 BCR GDI1 DICER1 LRCH3 PTPDC1 PPP2R1A EIF2B1 NEK8 ENAH NINL TRAPPC10 TTI1 RAI14 PRKD1 COPS6 CNOT1 ARMC8 | 5.62e-07 | 1321 | 170 | 22 | 27173435 |
| Pubmed | SMG1 NCAPD3 TRPC4AP CTNNAL1 LANCL1 URB2 GDI1 DNAH7 RYR2 ITPR3 MDN1 TIGD5 CNOT1 NIPBL TARBP1 | 6.45e-07 | 638 | 170 | 15 | 31182584 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TNPO1 NUMA1 URB2 HUWE1 DICER1 ITPR3 PPP2R1A NOP58 MDN1 UBR5 CLIC1 TLN1 NAT10 MKI67 UTP20 ALB MAP4K4 CNOT1 NIPBL | 7.26e-07 | 1024 | 170 | 19 | 24711643 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | USP34 NUMA1 ARMCX3 PPP2R1A MDN1 UBR5 NAT10 UTP20 BRAT1 MOCS1 | 7.32e-07 | 262 | 170 | 10 | 36880596 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IPPK CFAP47 NEMP1 PGAP3 TNPO2 OR13C8 HUWE1 ZZZ3 MDN1 TLN1 MCM3AP PLXNA4 UTP20 OR4B1 ALB CNOT1 | 7.55e-07 | 736 | 170 | 16 | 29676528 |
| Pubmed | 1.02e-06 | 210 | 170 | 9 | 16565220 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.11e-06 | 212 | 170 | 9 | 33853758 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CLASP1 USP28 HUWE1 BCR KANSL3 PPP2R1A ZZZ3 UBR5 ANAPC1 MCM3AP PLPBP YY1AP1 CDCA4 | 1.33e-06 | 588 | 170 | 14 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 NCAPD3 CLASP1 NUMA1 HUWE1 STRIP1 SPICE1 KANSL3 MDN1 ANAPC1 MKI67 TRAPPC10 UTP20 YY1AP1 MAP4K4 NIPBL | 1.45e-06 | 774 | 170 | 16 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NEMP1 NUP50 NCAPD3 MED10 MLX NUMA1 CHD1L NPM3 ITPR3 KANSL3 ORC5 PPP2R1A NOP58 ZZZ3 MDN1 ANAPC1 NAT10 MKI67 UTP20 TIGD5 NIPBL | 1.56e-06 | 1294 | 170 | 21 | 30804502 |
| Pubmed | 1.81e-06 | 225 | 170 | 9 | 12168954 | ||
| Pubmed | TNPO1 USP34 NUP50 CTNNAL1 LANCL1 HUWE1 MCM10 BCR GDI1 GDI2 DICER1 ARMCX3 NPM3 MRM3 PPP2R1A UBR5 ANAPC1 EIF2B1 ANP32A COPS6 ARMC8 | 2.55e-06 | 1335 | 170 | 21 | 29229926 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | NEMP1 TAPT1 ROR2 NUMA1 LRP1B ITPR3 LIFR MDN1 EIF2B1 TLN1 CNOT1 | 2.65e-06 | 375 | 170 | 11 | 32788342 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TNPO1 PRPSAP1 RNASEH2B USP34 NUP50 FAM114A1 RAP1GDS1 HUWE1 GDI1 GDI2 ARMCX3 NPM3 ABRAXAS2 PPP2R1A TLN1 ENAH ANP32A TTI1 PLPBP BRAT1 COPS6 CNOT1 | 2.73e-06 | 1455 | 170 | 22 | 22863883 |
| Pubmed | NUMA1 HUWE1 PPP2R1A NOP58 ZZZ3 ANAPC1 TLN1 NAT10 NFKBIE ENAH RAI14 MAP4K4 CNOT1 | 3.42e-06 | 549 | 170 | 13 | 38280479 | |
| Pubmed | 3.57e-06 | 129 | 170 | 7 | 23022380 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PRPSAP1 CLASP1 DGKZ SNRK BCR MADD SPICE1 ABRAXAS2 PTPDC1 NOP58 UBR5 EIF2B1 MCM3AP NFKBIE ENAH KNDC1 MAP4K4 CNOT1 | 3.72e-06 | 1038 | 170 | 18 | 26673895 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NCAPD3 NUMA1 HUWE1 PPP2R1A MDN1 ANAPC1 TLN1 NAT10 TTI1 NIPBL | 6.05e-06 | 332 | 170 | 10 | 32786267 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.39e-06 | 202 | 170 | 8 | 33005030 | |
| Pubmed | RALGAPA1 RAP1GDS1 CLASP1 DGKZ MTHFS BCR GDI1 GDI2 MADD STRIP1 LRCH3 PPP2R1A TLN1 PLXNA4 KNDC1 TRAPPC10 RAI14 ALB TNS1 CNOT1 ARMC8 | 7.40e-06 | 1431 | 170 | 21 | 37142655 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | USP34 SMG1 PCDHGA3 ROR2 NPHP4 DNAH7 MTMR10 PTPDC1 ZZZ3 NEK8 DNAH8 | 7.75e-06 | 420 | 170 | 11 | 28065597 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TNPO1 RALGAPA1 USP28 NUMA1 URB2 HUWE1 MCM10 NPM3 NOP58 NOP14 MDN1 CLIC1 NAT10 ANP32A MKI67 UTP20 BRAT1 | 7.87e-06 | 989 | 170 | 17 | 36424410 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E USP34 PGAP3 CARD10 HUWE1 NPHP4 BCR MADD ITPR3 KANSL3 ARHGEF40 LLGL2 MDN1 NEK8 TLN1 MCM3AP NINL BRAT1 | 8.72e-06 | 1105 | 170 | 18 | 35748872 |
| Pubmed | RALGAPA1 CLASP1 LANCL1 DGKZ ITIH1 LIFR UBR5 CTNNA3 TRAPPC10 RAI14 GULP1 | 9.66e-06 | 430 | 170 | 11 | 32581705 | |
| Pubmed | TNPO1 PRPSAP1 NCAPD3 CHD1L HUWE1 BCR ARMCX3 ORC5 METTL13 MDN1 ANAPC1 TTI1 BRAT1 | 9.86e-06 | 606 | 170 | 13 | 36538041 | |
| Pubmed | TNPO1 UBR1 MED10 WWC3 NUMA1 HUWE1 GDI1 GDI2 SPICE1 ITPR3 PPP2R1A NOP58 CLIC1 TLN1 NAT10 ANP32A MKI67 TRAPPC10 RAI14 | 1.24e-05 | 1247 | 170 | 19 | 27684187 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.27e-05 | 104 | 170 | 6 | 31240132 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 TRPC4AP ROR2 CHD1L HUWE1 NBEAP1 BCR LRCH3 SGK2 KANSL3 PTPDC1 NAT10 ENAH KNDC1 ZFHX2 RAI14 TRMT13 PRKD1 CFAP69 CNOT1 GULP1 | 1.34e-05 | 1489 | 170 | 21 | 28611215 |
| Pubmed | CLASP1 NUMA1 CHD1L DICER1 NPM3 KANSL3 MRM3 NOP58 METTL13 ARHGEF40 CLIC1 TCHHL1 EIF2B1 TLN1 MCM3AP NAT10 MKI67 RAI14 ROS1 CNOT1 | 1.35e-05 | 1371 | 170 | 20 | 36244648 | |
| Pubmed | NCAPD3 CLASP1 DGKZ URB2 DICER1 STRIP1 NPM3 LRCH3 ORC5 MRM3 NOP14 MDN1 CLIC1 ANAPC1 TLN1 CSTF1 UTP20 RAI14 NIPBL FHIP1A ARMC8 | 1.46e-05 | 1497 | 170 | 21 | 31527615 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | TNPO1 MED10 URB2 BCR MCOLN1 GDI2 KANSL3 NOP58 CSTF1 TTI1 UTP20 | 1.60e-05 | 454 | 170 | 11 | 33226137 |
| Pubmed | 1.93e-05 | 167 | 170 | 7 | 25659891 | ||
| Pubmed | 2.02e-05 | 33 | 170 | 4 | 26296893 | ||
| Pubmed | LRRC8E NUP50 NUMA1 HUWE1 ARMCX3 NPM3 PPP2R1A NOP58 CNOT1 HYDIN ARMC8 | 2.16e-05 | 469 | 170 | 11 | 27634302 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.17e-05 | 170 | 170 | 7 | 23314748 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18694729 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18586264 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 7585614 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16863910 | ||
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 2.38e-05 | 2 | 170 | 2 | 9298975 | |
| Pubmed | The CCR4-NOT complex maintains liver homeostasis through mRNA deadenylation. | 2.38e-05 | 2 | 170 | 2 | 32238456 | |
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 2.38e-05 | 2 | 170 | 2 | 24780099 | |
| Pubmed | A clinicopathological analysis of primary mucosal malignant melanoma. | 2.38e-05 | 2 | 170 | 2 | 25297929 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24285081 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10706130 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NCAPD3 CLASP1 NUMA1 URB2 MCM10 MRM3 NOP58 NOP14 MDN1 EIF2B1 NAT10 MKI67 UTP20 CNOT1 | 2.40e-05 | 759 | 170 | 14 | 35915203 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 2.70e-05 | 315 | 170 | 9 | 26777405 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP28 HUWE1 BCR SKP2 DICER1 STRIP1 ABRAXAS2 MRM3 UBR5 CSTF1 ALB COPS6 MAP4K4 CNOT1 TARBP1 ARMC8 | 3.71e-05 | 1005 | 170 | 16 | 19615732 |
| Pubmed | 3.78e-05 | 411 | 170 | 10 | 36652389 | ||
| Pubmed | 4.06e-05 | 332 | 170 | 9 | 25693804 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP1 NCAPD3 NUMA1 URB2 HUWE1 NPM3 NOP58 METTL13 UBR5 UTP20 DNAH8 CNOT1 NIPBL | 4.67e-05 | 704 | 170 | 13 | 29955894 |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 4.70e-05 | 80 | 170 | 5 | 19389623 | |
| Pubmed | NUP50 NUMA1 LANCL1 HUWE1 BCR LRCH3 ABRAXAS2 PPP2R1A NOP58 ARHGEF40 TLN1 ENAH ANP32A CSTF1 PLPBP | 4.78e-05 | 916 | 170 | 15 | 32203420 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TNPO1 TNPO2 HUWE1 GDI1 GDI2 NPM3 PPP2R1A NOP58 MDN1 UBR5 CLIC1 TLN1 ENAH ANP32A RAI14 COPS6 CNOT1 | 5.24e-05 | 1149 | 170 | 17 | 35446349 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SMG1 NEMP1 URB2 MCOLN1 MADD NOP14 UBR5 EIF2B1 ANP32A PTCD2 RAI14 MAP4K4 TARBP1 | 5.78e-05 | 719 | 170 | 13 | 35337019 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.67e-05 | 440 | 170 | 10 | 34244565 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP1 CLASP1 NUMA1 LANCL1 HUWE1 ARMCX3 NPM3 MRM3 PPP2R1A NOP58 UBR5 CLIC1 TLN1 ENAH ANP32A PLPBP NIPBL TARBP1 CWF19L1 | 6.85e-05 | 1415 | 170 | 19 | 28515276 |
| Pubmed | RALGAPA1 USP34 CLASP1 HUWE1 MCM10 BCR DICER1 MADD STRIP1 ANAPC1 EIF2B1 PLPBP MAP4K4 | 7.02e-05 | 733 | 170 | 13 | 34672954 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 26240314 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 8970164 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 31213560 | ||
| Pubmed | LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome. | 7.10e-05 | 3 | 170 | 2 | 33932340 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 17360756 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 19718053 | ||
| Pubmed | PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis. | 7.10e-05 | 3 | 170 | 2 | 19121999 | |
| Pubmed | ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia. | 7.10e-05 | 3 | 170 | 2 | 29269781 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 38421166 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 30905620 | ||
| Pubmed | Identification of sequences required for inhibition of oncogene-mediated transformation by pp32. | 7.10e-05 | 3 | 170 | 2 | 10400610 | |
| Pubmed | LanCL proteins are not Involved in Lanthionine Synthesis in Mammals. | 7.10e-05 | 3 | 170 | 2 | 28106097 | |
| Pubmed | Characterization of the TRBP domain required for dicer interaction and function in RNA interference. | 7.10e-05 | 3 | 170 | 2 | 19422693 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 38280476 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 36370958 | ||
| Pubmed | Modulation of oncogenic potential by alternative gene use in human prostate cancer. | 7.10e-05 | 3 | 170 | 2 | 10086381 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 26246398 | ||
| Pubmed | Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling. | 7.10e-05 | 3 | 170 | 2 | 34962618 | |
| Pubmed | The expression and distributions of ANP32A in the developing brain. | 7.10e-05 | 3 | 170 | 2 | 25866766 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 7543319 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 33483464 | ||
| Pubmed | Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway. | 7.10e-05 | 3 | 170 | 2 | 18162545 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 7513052 | ||
| Pubmed | Tumor suppression and potentiation by manipulation of pp32 expression. | 7.10e-05 | 3 | 170 | 2 | 11360199 | |
| Pubmed | ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. | 7.10e-05 | 3 | 170 | 2 | 20606625 | |
| Interaction | SIRT7 interactions | TNPO1 USP34 NUMA1 URB2 HUWE1 GDI1 GDI2 DICER1 ITPR3 PPP2R1A NOP58 NOP14 MDN1 UBR5 ANAPC1 TLN1 MCM3AP NAT10 MKI67 UTP20 CNOT1 NIPBL | 1.72e-07 | 744 | 164 | 22 | int:SIRT7 |
| Interaction | C3orf18 interactions | 4.23e-07 | 115 | 164 | 9 | int:C3orf18 | |
| Interaction | PTP4A3 interactions | PRPSAP1 TNPO2 HUWE1 SKP2 MCOLN1 DICER1 LRCH3 UBR5 RAI14 CXCL12 | 5.43e-07 | 154 | 164 | 10 | int:PTP4A3 |
| Interaction | SCN2B interactions | 1.26e-05 | 95 | 164 | 7 | int:SCN2B | |
| Interaction | GYPA interactions | 1.30e-05 | 174 | 164 | 9 | int:GYPA | |
| Interaction | RDX interactions | RNASEH2B NUP50 ROR2 BCR GDI2 PPP2R1A CLIC1 TLN1 TRAPPC10 RAI14 MAP4K4 | 2.19e-05 | 284 | 164 | 11 | int:RDX |
| Interaction | VSIG1 interactions | 2.66e-05 | 72 | 164 | 6 | int:VSIG1 | |
| Interaction | FOXD4L6 interactions | 4.79e-05 | 49 | 164 | 5 | int:FOXD4L6 | |
| Interaction | TNFSF13B interactions | 5.43e-05 | 119 | 164 | 7 | int:TNFSF13B | |
| Interaction | CDC5L interactions | TNPO1 CLASP1 CARD10 CHD1L HUWE1 MCM10 ORC5 PPP2R1A NOP14 MDN1 UBR5 ANAPC1 TLN1 NAT10 ENAH CNOT1 NIPBL CWF19L1 GULP1 | 7.04e-05 | 855 | 164 | 19 | int:CDC5L |
| Interaction | IFI16 interactions | PRPSAP1 NUP50 NUMA1 URB2 HUWE1 LRCH3 MRM3 PPP2R1A NOP58 NOP14 EIF2B1 MCM3AP NAT10 MKI67 UTP20 RAI14 CNOT1 | 7.54e-05 | 714 | 164 | 17 | int:IFI16 |
| Interaction | BRCA1 interactions | TNPO1 CFAP47 UBR1 NCAPD3 FLT3 SDK2 USP28 NUMA1 HUWE1 MCM10 SKP2 ZZZ3 MDN1 UBR5 CLIC1 TLN1 NAT10 MKI67 CSTF1 NINL BRAT1 MAP4K4 CNOT1 NIPBL | 7.55e-05 | 1249 | 164 | 24 | int:BRCA1 |
| GeneFamily | ANP32 acidic nuclear phosphoproteins | 3.18e-04 | 5 | 103 | 2 | 27 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.93e-04 | 181 | 103 | 6 | 694 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 6.63e-04 | 7 | 103 | 2 | 785 | |
| GeneFamily | SPOUT methyltranferase domain containing | 8.80e-04 | 8 | 103 | 2 | 1294 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.52e-03 | 40 | 103 | 3 | 321 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.88e-03 | 43 | 103 | 3 | 409 | |
| GeneFamily | Ubiquitin specific peptidases | 4.00e-03 | 56 | 103 | 3 | 366 | |
| GeneFamily | Dyneins, axonemal | 4.13e-03 | 17 | 103 | 2 | 536 | |
| GeneFamily | Armadillo repeat containing|Importins | 4.63e-03 | 18 | 103 | 2 | 596 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | RAP1GDS1 MED10 PRAMEF5 GDI2 NOP58 MCM3AP ANP32A MKI67 ANP32D PRAMEF6 | 2.68e-07 | 180 | 168 | 10 | MM612 |
| Coexpression | GABRIELY_MIR21_TARGETS | B3GALNT1 TNPO1 USP34 SKP2 ARMCX3 LIFR PTPDC1 UBR5 ENAH RAI14 NIPBL | 2.83e-06 | 289 | 168 | 11 | M2196 |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 4.36e-05 | 198 | 168 | 8 | M3200 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 4.68e-05 | 200 | 168 | 8 | M9484 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_12H_BMDC_UP | 4.68e-05 | 200 | 168 | 8 | M3814 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 4.68e-05 | 200 | 168 | 8 | M3830 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 4.68e-05 | 200 | 168 | 8 | M7831 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-08 | 179 | 170 | 9 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-07 | 185 | 170 | 8 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.34e-07 | 194 | 170 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.46e-06 | 157 | 170 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 180 | 170 | 7 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 180 | 170 | 7 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 181 | 170 | 7 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 181 | 170 | 7 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-06 | 189 | 170 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.93e-06 | 191 | 170 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-06 | 192 | 170 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-06 | 192 | 170 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.55e-06 | 193 | 170 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 194 | 170 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 194 | 170 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 194 | 170 | 7 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.88e-06 | 194 | 170 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.06e-05 | 196 | 170 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.09e-05 | 197 | 170 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 197 | 170 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 197 | 170 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 197 | 170 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 170 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-05 | 200 | 170 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 157 | 170 | 6 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 157 | 170 | 6 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.74e-05 | 162 | 170 | 6 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 4.74e-05 | 169 | 170 | 6 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 169 | 170 | 6 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-05 | 169 | 170 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 169 | 170 | 6 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-05 | 172 | 170 | 6 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 5.40e-05 | 173 | 170 | 6 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-05 | 176 | 170 | 6 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 180 | 170 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 180 | 170 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 180 | 170 | 6 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-05 | 185 | 170 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.82e-05 | 185 | 170 | 6 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.82e-05 | 185 | 170 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 185 | 170 | 6 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.06e-05 | 186 | 170 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 8.54e-05 | 188 | 170 | 6 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.54e-05 | 188 | 170 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.54e-05 | 188 | 170 | 6 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 8.68e-05 | 61 | 170 | 4 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 189 | 170 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.06e-05 | 190 | 170 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 190 | 170 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.06e-05 | 190 | 170 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.32e-05 | 191 | 170 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 191 | 170 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.32e-05 | 191 | 170 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.32e-05 | 191 | 170 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 191 | 170 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 191 | 170 | 6 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 191 | 170 | 6 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-05 | 192 | 170 | 6 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-05 | 192 | 170 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 9.59e-05 | 192 | 170 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.59e-05 | 192 | 170 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-05 | 192 | 170 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-05 | 192 | 170 | 6 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-05 | 192 | 170 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-05 | 192 | 170 | 6 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 9.87e-05 | 193 | 170 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 9.87e-05 | 193 | 170 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 9.87e-05 | 193 | 170 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 9.87e-05 | 193 | 170 | 6 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-04 | 194 | 170 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 194 | 170 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 194 | 170 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 194 | 170 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.04e-04 | 195 | 170 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 195 | 170 | 6 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.04e-04 | 195 | 170 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 195 | 170 | 6 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 195 | 170 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.04e-04 | 195 | 170 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.04e-04 | 195 | 170 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.07e-04 | 196 | 170 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 196 | 170 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.07e-04 | 196 | 170 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 197 | 170 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late-42|World / Primary Cells by Cluster | 1.10e-04 | 197 | 170 | 6 | 0057aa4bce8684711b061710eab1d2b85e14e055 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 170 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late|World / Primary Cells by Cluster | 1.10e-04 | 197 | 170 | 6 | 9a65a54e097947601d8e382c4f4b4f5c2c1df51c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 199 | 170 | 6 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 199 | 170 | 6 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 199 | 170 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 1.17e-04 | 199 | 170 | 6 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-04 | 199 | 170 | 6 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-04 | 200 | 170 | 6 | 4c22a1f35ff496fa6af2ab171f2936785272bc06 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-04 | 200 | 170 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-04 | 200 | 170 | 6 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Stem_cells-Neuroepithelial_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-04 | 200 | 170 | 6 | 0632b8d3a1be437f146bc86aae9646303e37a0bd | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-04 | 144 | 170 | 5 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | IPPK B3GALNT1 CARD10 URB2 SKP2 UBR5 UTP20 RAI14 TRMT13 NIPBL CWF19L1 CXCL12 | 1.51e-08 | 189 | 166 | 12 | 1065_DN |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.49e-04 | 206 | 162 | 7 | C0152013 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.53e-04 | 49 | 162 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 | 2.96e-04 | 5 | 162 | 2 | C1832931 | |
| Disease | Drug habituation | 4.43e-04 | 115 | 162 | 5 | C0013170 | |
| Disease | Drug abuse | 4.43e-04 | 115 | 162 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.43e-04 | 115 | 162 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.43e-04 | 115 | 162 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 4.43e-04 | 115 | 162 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.43e-04 | 115 | 162 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.43e-04 | 115 | 162 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.43e-04 | 115 | 162 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.43e-04 | 115 | 162 | 5 | C0029231 | |
| Disease | Substance abuse problem | 4.60e-04 | 116 | 162 | 5 | C0740858 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.09e-04 | 181 | 162 | 6 | DOID:684 (is_implicated_in) | |
| Disease | LEUKEMIA, ACUTE LYMPHOBLASTIC | 8.21e-04 | 8 | 162 | 2 | 613065 | |
| Disease | Acute lymphoid leukemia | 8.21e-04 | 8 | 162 | 2 | cv:C0023449 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 8.21e-04 | 8 | 162 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | Nephronophthisis | 1.05e-03 | 9 | 162 | 2 | cv:C0687120 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | NG-monomethyl-arginine measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0010510 | |
| Disease | candidiasis (implicated_via_orthology) | 1.82e-03 | 44 | 162 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | Acute Promyelocytic Leukemia | 2.07e-03 | 46 | 162 | 3 | C0023487 | |
| Disease | Cakut | 2.25e-03 | 13 | 162 | 2 | C1968949 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.25e-03 | 13 | 162 | 2 | C3501611 | |
| Disease | Nephronophthisis | 2.25e-03 | 13 | 162 | 2 | C0687120 | |
| Disease | HIV Infections | 2.54e-03 | 103 | 162 | 4 | C0019693 | |
| Disease | HIV Coinfection | 2.54e-03 | 103 | 162 | 4 | C4505456 | |
| Disease | diffuse idiopathic skeletal hyperostosis | 3.00e-03 | 15 | 162 | 2 | EFO_0007236 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 3.00e-03 | 15 | 162 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | cancer (implicated_via_orthology) | 3.73e-03 | 268 | 162 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | bipolar disorder | 4.74e-03 | 577 | 162 | 9 | MONDO_0004985 | |
| Disease | methadone dose measurement | 4.85e-03 | 62 | 162 | 3 | EFO_0007907 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ISHQCFLPNKEQVLL | 31 | Q14146 | |
| ILPCIKELVSDANQH | 326 | P30153 | |
| PAIQQVLKRLCDLHA | 566 | Q99424 | |
| VVLLQEHPCLVELLS | 46 | Q6PJG6 | |
| PHALCVKAQEILRLV | 721 | Q9BWT7 | |
| LQVIEIHNHQPCSKL | 51 | Q15018 | |
| LNQLCVLHEKTPVSD | 481 | P02768 | |
| PLCLHEQVVVQLAAL | 81 | Q8TER5 | |
| IHVHKQVCEIIESPL | 136 | Q7L5N1 | |
| QVCEIIESPLFLKLN | 141 | Q7L5N1 | |
| VLVICVVKLNPSLQT | 31 | P0DMS8 | |
| QECKALQRVAILVPH | 116 | O60513 | |
| CVKLQTVHSIPLTIN | 886 | P11274 | |
| NCIHRDIKPENILIT | 121 | Q5MAI5 | |
| EIRQILENPCSLKHL | 526 | Q8WXK1 | |
| EVLAEKCPNLTHLNL | 81 | P39687 | |
| SLQNKQILVPELCAI | 1026 | Q9UPY3 | |
| TVLSPQELQKVLCLV | 116 | Q9UH62 | |
| CRVTPLQKAQVVELV | 806 | P98198 | |
| IVKHVNTNPLCDLTP | 171 | Q9UKX7 | |
| IAPVQVCTNLLIKQV | 116 | Q8NDN9 | |
| CLQAVQILCEHKSPI | 131 | Q9P0K7 | |
| ECKQHLLANDIPRIL | 131 | Q9H082 | |
| LAHIQKNPVLDCSIA | 1011 | P20702 | |
| EVVQLPLEFVKQLCL | 76 | Q9H8X2 | |
| NHIAIPVTQELICKC | 641 | Q14573 | |
| IPISLETQAHIQECK | 271 | Q9GZU1 | |
| HCKPQTLREIVIGVL | 276 | Q9UH92 | |
| ELVQTCLQAIKFILP | 616 | Q9H1A4 | |
| LALAFKEQICLQVPV | 171 | P49914 | |
| KLNLSCIHSPVVNEL | 101 | Q9Y2X3 | |
| THIQCSIKPHAIIIL | 1111 | O95819 | |
| QVDHFICEVPVLIKL | 176 | Q8NGZ5 | |
| QVIRVICILSHPIKN | 296 | P50395 | |
| NIVHCDLKPENVLLA | 701 | Q15139 | |
| QEQLCLPLHILEEKG | 736 | Q96II8 | |
| ASHPIVQKLICQHIV | 1001 | Q9NU22 | |
| VCVTLIDLELHNPKA | 316 | Q9NZR2 | |
| QVLTCILLEHKVVLQ | 311 | Q8WXG6 | |
| KAILEHLKQICTPQN | 1251 | Q8IV33 | |
| VTQIHLLPGQCQLVT | 76 | Q6P1M3 | |
| VEKIPQSHIQQICET | 171 | O43813 | |
| CHQLLHPQVLQLLVK | 461 | Q8IXH7 | |
| IIHVPQKEDTLCFNI | 676 | P19827 | |
| HQEIAVPVANLKLSC | 91 | O75607 | |
| PLTCIEQIVTVNDHK | 101 | Q9NXD2 | |
| LACLHIATLQKNQPL | 371 | O00221 | |
| QQHLCDPLTVSLIEK | 736 | O60318 | |
| GICLNLLKVNIHIPE | 271 | O75752 | |
| CLASPEVEKHLVVNI | 331 | Q69YN2 | |
| KALCHLNVPVTVVLD | 166 | Q14232 | |
| KQCVRLTVHPNNISV | 556 | Q9HCM2 | |
| ILCEHPNQVSPVKIC | 211 | Q9HBH9 | |
| IIIALCTKNLEHPIQ | 306 | O14524 | |
| KLNIPCLGLEINHTI | 466 | Q96JB1 | |
| LEVVQKCIPFLIGHL | 231 | Q14D04 | |
| TALVLQLIQCVVHLP | 1491 | Q6KC79 | |
| QLIQCVVHLPSSEKD | 1496 | Q6KC79 | |
| ECQVLKLLNHPNVIE | 51 | Q86SG6 | |
| EVLTPAQIKSICQAI | 191 | Q6ZV70 | |
| QVTQDKIICLPNHEL | 46 | Q6NSJ5 | |
| KIICLPNHELQENLS | 51 | Q6NSJ5 | |
| EEVCLSIDHPQKVLI | 366 | Q7L590 | |
| DIRIQLPVVSKQHCK | 36 | P46013 | |
| LCVLHCIVNLQTIPV | 686 | A2A3K4 | |
| IDKCRQQLHDITVPL | 51 | Q9BTT4 | |
| EQLLVVERIQKCNHP | 446 | P78316 | |
| LLQVACINTHLIEKI | 181 | Q8NGM8 | |
| VLIKLLEVVQPCLQA | 1556 | Q7Z6Z7 | |
| KCLVIDDQLNILPIS | 196 | Q9H0A0 | |
| VQAAKVTSQLIPLCH | 541 | Q9NZB8 | |
| IAVLCLTVELQPHVV | 1116 | O75161 | |
| CQSAIKILHPLIQAV | 131 | Q7RTS6 | |
| CAQIPLCLVKINILV | 96 | Q9Y5H0 | |
| NTLQCTAHLPEVKEL | 156 | Q5VZV1 | |
| KIAANHLETLCPQII | 446 | Q9UI47 | |
| TNQDLPVIKCVLINH | 26 | P36888 | |
| CLTLLVEIHPVNNVK | 126 | A4D1B5 | |
| NNVKSLLDCHIIPAL | 96 | Q8IUR7 | |
| PTVEEKLVVLLNQLC | 156 | Q05DH4 | |
| NLICNVEKKVHPVTL | 4166 | Q4G0P3 | |
| SKILHIPQVTKLCVQ | 161 | Q9P2G3 | |
| NKLIPLCHQLQTVTK | 661 | Q9UBT7 | |
| ILEPKTKEVQHNCQL | 81 | Q9UBP9 | |
| LQNILSQLRKCVDHP | 311 | Q86WJ1 | |
| VEDFKQHIPLIQVIC | 831 | Q8WXX0 | |
| VIPTLVKLLGIHCQN | 181 | P52306 | |
| EGQLKLCVVQPVHLT | 6 | Q2M3T9 | |
| CLGKVIPVATHLLNN | 301 | Q9P2N6 | |
| VVTNTVPHEVQKLQC | 306 | Q14558 | |
| LTLLQQELFQKCHPV | 1476 | Q76NI1 | |
| QVIRIICILSHPIKN | 296 | P31150 | |
| RKIQDHQVVINCAIP | 51 | Q8N8S7 | |
| AACKIVVHTPCIEQL | 131 | Q13574 | |
| VVHTPCIEQLEKINF | 136 | Q13574 | |
| QSVCAPSEQLLHLIK | 41 | Q05048 | |
| VNEILFCQLHPEQKL | 646 | Q8N6R0 | |
| LKQLCDHILFINPAI | 36 | P0C6P0 | |
| FNVIVILCKDLPTVQ | 371 | A5D8W1 | |
| ECVANARPLIKLHII | 236 | Q58EX2 | |
| HCVLVESPEALNIIK | 576 | Q92736 | |
| EIQCIIKNQCELLPV | 431 | Q6ZTR5 | |
| IQCDLGKHVTQIIPL | 2651 | Q6ZTR5 | |
| QIIPLVNCTHETLKL | 2661 | Q6ZTR5 | |
| PQQLNCETHDLKEII | 336 | P42702 | |
| NPESIACINLNIIIH | 266 | Q8WV60 | |
| LPVLQVSHIQTSCLK | 546 | Q8IWE2 | |
| LVSELLPAKHLCQQL | 1356 | Q14980 | |
| PHVRKCVVVVLLLQG | 251 | Q96FM1 | |
| NNVIKHFVCEILAIL | 171 | Q8NGS7 | |
| FCHSIIQILVIIQLP | 151 | Q8NGF8 | |
| HPNIVRLIGVCTQKQ | 616 | P07332 | |
| VDILVTVQNLLKHCV | 1371 | O75691 | |
| DIQHLCLNKIPVLRE | 241 | Q9NUP7 | |
| HCNLPKLRVILGVTI | 56 | Q8IYP2 | |
| KPENILLDCQGHVVL | 161 | Q9HBY8 | |
| FVECQNILKEISPLL | 91 | Q8TEL6 | |
| KTQLQHSLPLLLICD | 201 | Q9HC36 | |
| LKTLELPHVFVNCVE | 51 | O43913 | |
| VCLPVSLLQLIAQHS | 1056 | Q9NTG1 | |
| TCLVQLLKQCHLVPQ | 2816 | Q96Q15 | |
| AQHLVFANCIPLILK | 601 | Q5VSL9 | |
| DQHQVLVCTKLVEPF | 51 | Q86WV5 | |
| LQHPNVVCLLGVVTK | 531 | Q01974 | |
| CLKLHLEQQLPVLLQ | 36 | Q9Y2I6 | |
| TIAIVEHINAKCPNL | 161 | O94903 | |
| RQHKCALLLQEIPAI | 146 | Q4LDE5 | |
| LQLPLCEKTISVNIQ | 731 | Q9NRH2 | |
| NTTEVQKHIPLCALL | 1056 | Q13018 | |
| EQLISLTHAIKNCPV | 441 | Q8N0Z3 | |
| EVLAEKCPNLIHLNL | 81 | O95626 | |
| KVLVTQKLPNILCHV | 626 | Q8N957 | |
| QKLPNILCHVKIREN | 631 | Q8N957 | |
| SLVKLQLCHMLVEPN | 41 | Q9BXL8 | |
| ADCNLLPKLHIVQVV | 176 | O00299 | |
| PVVRILLQHICAKVV | 351 | P42695 | |
| QTLTLSKIVPHICNL | 161 | Q7Z460 | |
| TQFLIQECALLITKP | 71 | A5YKK6 | |
| LQLLKEALPHLQINC | 376 | Q13309 | |
| VLNHAAVPLISNKIC | 356 | P57727 | |
| ENLLSHTIILKNLCV | 396 | Q5VXH4 | |
| CIVQALTHIPLLKDF | 376 | Q70EK9 | |
| LHNVVPECVEKLLLV | 1031 | Q9C0A1 | |
| VCCDPLVLAQQLTHI | 211 | Q8N9B8 | |
| HPQIKEALNVICVSL | 1311 | Q6GYQ0 | |
| PQVIKLACIDTHVIE | 186 | P0C645 | |
| VVVDNVFPNCILLLK | 116 | Q5TBB1 | |
| LLVQSCKAVAEQIPL | 951 | Q9Y490 | |
| ICKEVLASHLVQLIP | 286 | O14787 | |
| TEPLEAINQLQKLCH | 61 | Q92670 | |
| QHSIIPLALPCKLVI | 1556 | Q9HBL0 | |
| ENLLSHTIILKNLCV | 396 | Q5TYX0 | |
| RITCPQVLIQKHLVR | 1366 | Q8IWV7 | |
| PQLVLQLCIIVQTHS | 316 | Q5GH76 | |
| HPNILKQLGVCLLNE | 2006 | P08922 | |
| ELIIPCIHLIINNDI | 981 | Q96RU2 | |
| HVVVELITCNVILPL | 236 | Q92543 | |
| LAEQPICKDVLVRHL | 291 | Q92973 | |
| VQLLTQIHLLATCNP | 176 | Q9H869 | |
| LLHKIPLICQQFEAD | 126 | Q6UXN7 | |
| QPAQVCDILKGVILV | 156 | Q6NXT6 | |
| SDQVLPVFHCLKVLV | 941 | Q13395 | |
| PNLHIEIIKQCQVIL | 381 | Q70CQ2 | |
| QPCVLHAVEKNSNLL | 46 | Q5QJ38 | |
| VGPQQVLCLLLEHLK | 466 | Q9Y4F4 | |
| QILQEETKVCLNILP | 1631 | Q9BXT5 | |
| HNCVQELKLLEVSVP | 336 | P48553 | |
| RSCLQQKAVLLVAHP | 346 | Q53EQ6 | |
| HLKILNTPNCALQIV | 46 | P48061 | |
| QIKHIIRNCLLSVEP | 286 | Q8NG68 | |
| KIVTACLPVEHVNQL | 281 | Q8IYH5 | |
| CLLVHVLQLKNPAGL | 616 | Q9ULE0 | |
| LATQTVVPLQHCKIP | 56 | Q9GZU3 | |
| CPITLNRHVIKVLLG | 2546 | O95071 | |
| LDVLDLCVVVLQSHK | 886 | O43156 | |
| LCVVVLQSHKNQLLP | 891 | O43156 | |
| LITHICKSLPLLENQ | 331 | P20591 | |
| RCNKVHIQPVITDLV | 91 | Q9Y5N5 |